Suppr超能文献

肺功能差的肺癌患者的外科治疗

[Surgical treatment for lung cancer patients with poor pulmonary function].

作者信息

Mao Yousheng, Zhang Dechao, Zhang Rugang, Wang Liangjun, Yang Lin, Cheng Guiyu, Sun Kelin

机构信息

Department of Thoracic Surgical Oncology, Cancer Institute (Hospital), Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100021, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2002 May;24(3):300-2.

Abstract

OBJECTIVE

To summarize surgical treatment of lung cancer patients with poor pulmonary function.

METHODS

From 1991 to 1999, 181 lung cancer patients with poor pulmonary function underwent operation. The correlation between the results of preoperative pulmonary functional tests and the postoperative cardiopulmonary complications was analyzed by Chi-square test (chi(2)).

RESULTS

In 181 patients, pneumonectomy was done in 43, lobectomy in 118, partial lung resection in 16 and exploration in 4. The postoperative complication and mortality rates of the resection group were 42.3% (75/177) and 7.9% (14/177). The cardiopulmonary complication rates were 25.6%, 48.3%, 31.3% in pneumonectomy, lobectomy and partial lung resection. The morbidity and mortality rates of 8 patients who received preoperative chemotherapy and/or radiotherapy were 75.0% and 37.5%. The morbidity and mortality rates of 12 patients who had had a previous history of thoracotomy were 66.7% and 33.3%. In the present series, the 1-, 3- and 5-year survival rates were 71.1%, 42.2% and 31.1%. The 5-year survival rates of patients with stage I, II and III lesions were 55.0%, 25.0% and 0.

CONCLUSION

Preoperative spirometry is an important evaluation test for lung cancer patients with poor pulmonary function. It should be evaluated in combination with other pulmonary function tests such as CO(2) diffusion and cardiopulmonary excise tests, etc whenever possible. Patients with a history of thoracotomy, chemotherapy and radiotherapy should be carefully evaluated before operation to avoid high morbidity and mortality. Stage I and II lung cancer patients with poor pulmonary function can undergo operation if they have been well managed preoperatively and well taken care of with nursing care perioperatively.

摘要

目的

总结肺功能差的肺癌患者的外科治疗情况。

方法

1991年至1999年,181例肺功能差的肺癌患者接受了手术。采用卡方检验(χ²)分析术前肺功能测试结果与术后心肺并发症之间的相关性。

结果

181例患者中,43例行全肺切除术,118例行肺叶切除术,16例行肺部分切除术,4例行探查术。切除组的术后并发症发生率和死亡率分别为42.3%(75/177)和7.9%(14/177)。全肺切除术、肺叶切除术和肺部分切除术的心肺并发症发生率分别为25.6%、48.3%、31.3%。8例接受术前化疗和/或放疗患者的发病率和死亡率分别为75.0%和37.5%。12例有开胸手术史患者的发病率和死亡率分别为66.7%和33.3%。在本系列中,1年、3年和5年生存率分别为71.1%、42.2%和31.1%。Ⅰ期、Ⅱ期和Ⅲ期病变患者的5年生存率分别为55.0%、25.0%和0。

结论

术前肺活量测定是评估肺功能差的肺癌患者的重要检查。应尽可能结合其他肺功能检查,如二氧化碳弥散和心肺运动试验等进行评估。有开胸手术史、化疗和放疗史的患者术前应仔细评估,以避免高发病率和死亡率。术前管理良好且围手术期护理得当的Ⅰ期和Ⅱ期肺功能差的肺癌患者可以接受手术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验